You just read:

EMBL Ventures Portfolio Company, ViraTherapeutics, Acquired by Boehringer Ingelheim in EUR 210 Million (USD 245 Million) Transaction

News provided by

EMBL Ventures

13 Sep, 2018, 07:00 BST